UBS (Lux) Equity Fund - Biotech (SEK) P Fonds
1.017,88
SEK
+5,02
SEK
+0,50
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 9,32% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 6,44% |
| Neurocrine Biosciences Inc | US64125C1099 | 4,47% |
| Ionis Pharmaceuticals Inc | US4622221004 | 4,45% |
| AbbVie Inc | US00287Y1091 | 4,33% |
| Guardant Health Inc | US40131M1099 | 4,27% |
| Gilead Sciences Inc | US3755581036 | 3,58% |
| Amgen Inc | US0311621009 | 3,49% |
| Roivant Sciences Ltd Ordinary Shares | BMG762791017 | 3,44% |
| Sandoz Group AG Registered Shares | CH1243598427 | 3,22% |
| Sonstige | 52,99% |